Serological Biomarkers of Chronic Migraine

[1] Loder E(2001)Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 89-95

[2] Rizzoli P(2006)Biomarkers in migraine: their promise, problems, and practical applications Headache 46 1046-1058

[3] Phillips KA(2006)Diagnostics and biomarker development: priming the pipeline Nat Rev Drug Discov 5 463-469

[4] Van Bebber S(2013)Biomarkers associated with migraine and their potential role in migraine management Headache 53 1262-1277

[5] Issa AM(2009)Conceptualizing the relationship between chronic migraine and episodic migraine Expert Rev Neurother 9 1451-1454

[6] Durham P(2017)Cutaneous allodynia is more frequent in chronic migraine, and its presence and severity seems to be more associated with the duration of the disease Arq Neuropsiquiatr 75 153-159

[7] Papapetropoulos S(2017)Migraine biomarkers in cerebrospinal fluid: a systematic review and meta-analysis Cephalalgia 37 49-63

[8] Lipton RB(2022)Blood biomarkers from research use to clinical practice: what must be done? A Report from the EU/US CTAD Task Force J Prev Alzheimers Dis 9 569-579

[9] Chu MK(2014)Calcitonin gene-related peptide: physiology and pathophysiology Physiol Rev 94 1099-1142

[10] Benatto MT(2021)CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs J Headache Pain 22 128-56

[1] Loder E(2001)Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 89-95

[2] Rizzoli P(2006)Biomarkers in migraine: their promise, problems, and practical applications Headache 46 1046-1058

[3] Phillips KA(2006)Diagnostics and biomarker development: priming the pipeline Nat Rev Drug Discov 5 463-469

[4] Van Bebber S(2013)Biomarkers associated with migraine and their potential role in migraine management Headache 53 1262-1277

[5] Issa AM(2009)Conceptualizing the relationship between chronic migraine and episodic migraine Expert Rev Neurother 9 1451-1454

[6] Durham P(2017)Cutaneous allodynia is more frequent in chronic migraine, and its presence and severity seems to be more associated with the duration of the disease Arq Neuropsiquiatr 75 153-159

[7] Papapetropoulos S(2017)Migraine biomarkers in cerebrospinal fluid: a systematic review and meta-analysis Cephalalgia 37 49-63

[8] Lipton RB(2022)Blood biomarkers from research use to clinical practice: what must be done? A Report from the EU/US CTAD Task Force J Prev Alzheimers Dis 9 569-579

[9] Chu MK(2014)Calcitonin gene-related peptide: physiology and pathophysiology Physiol Rev 94 1099-1142

[10] Benatto MT(2021)CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs J Headache Pain 22 128-56